JP2008509912A5 - - Google Patents

Download PDF

Info

Publication number
JP2008509912A5
JP2008509912A5 JP2007525749A JP2007525749A JP2008509912A5 JP 2008509912 A5 JP2008509912 A5 JP 2008509912A5 JP 2007525749 A JP2007525749 A JP 2007525749A JP 2007525749 A JP2007525749 A JP 2007525749A JP 2008509912 A5 JP2008509912 A5 JP 2008509912A5
Authority
JP
Japan
Prior art keywords
optionally substituted
substituted
heterocyclyl
heteroaryl
aralkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007525749A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008509912A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/028357 external-priority patent/WO2006020680A2/en
Publication of JP2008509912A publication Critical patent/JP2008509912A/ja
Publication of JP2008509912A5 publication Critical patent/JP2008509912A5/ja
Pending legal-status Critical Current

Links

JP2007525749A 2004-08-10 2005-08-09 医薬品としての複素環化合物 Pending JP2008509912A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60023904P 2004-08-10 2004-08-10
PCT/US2005/028357 WO2006020680A2 (en) 2004-08-10 2005-08-09 Heterocyclic compounds as pharmaceutical agents

Publications (2)

Publication Number Publication Date
JP2008509912A JP2008509912A (ja) 2008-04-03
JP2008509912A5 true JP2008509912A5 (cg-RX-API-DMAC7.html) 2008-09-25

Family

ID=35908114

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007525749A Pending JP2008509912A (ja) 2004-08-10 2005-08-09 医薬品としての複素環化合物

Country Status (9)

Country Link
US (1) US7902237B2 (cg-RX-API-DMAC7.html)
EP (1) EP1776112A4 (cg-RX-API-DMAC7.html)
JP (1) JP2008509912A (cg-RX-API-DMAC7.html)
CN (1) CN101010078A (cg-RX-API-DMAC7.html)
AU (1) AU2005272916A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0514269A (cg-RX-API-DMAC7.html)
CA (1) CA2574279A1 (cg-RX-API-DMAC7.html)
MX (1) MX2007001539A (cg-RX-API-DMAC7.html)
WO (1) WO2006020680A2 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090156644A1 (en) * 2005-07-21 2009-06-18 Jacob Westman Use of thiazole derivatives and analogues in the treatment of cancer
DE102007003524A1 (de) * 2007-01-19 2008-09-04 MEDICE Arzneimittel Pütter GmbH & Co. KG Arzneimittel zur Behandlung und/oder Prävention von Arteriosklerose
WO2008090356A1 (en) * 2007-01-25 2008-07-31 Betagenon Ab Thiazolidinone derivatives useful in the treatment of cancer and disorders caused by excess adiposity
CN101274918A (zh) * 2007-03-30 2008-10-01 中国科学院上海药物研究所 一类取代五元杂环化合物,其制备方法和医学用途
WO2010086613A1 (en) 2009-01-30 2010-08-05 Betagenon Ab Compounds useful as inhibitors as ampk
WO2012106581A1 (en) * 2011-02-03 2012-08-09 The University Of Chicago Fxr inhibitor, bile acid sequestrant as combination therapy for cholesterol reduction
ES2822375T3 (es) * 2012-06-19 2021-04-30 Intercept Pharmaceuticals Inc Preparación de la forma no cristalina del ácido obeticólico
BR112016002268B1 (pt) 2013-08-01 2022-11-01 The Penn State Research Foundation Uso de inibidores do receptor x farnesoide
MX377523B (es) 2013-09-11 2025-03-10 Inst Nat Sante Rech Med Metodos y composiciones farmaceuticas para el tratamiento de la infeccion por el virus de la hepatitis b.
EP2952188A1 (en) * 2014-06-03 2015-12-09 Universität Bern Thiazolidinones as cellular anandamide uptake inhibitors and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation
US10300048B2 (en) 2014-05-28 2019-05-28 Universitat Bern Thiazolidinones as cellular anandamide uptake inhibitors and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation
RU2021107054A (ru) 2015-03-26 2021-03-31 Акарна Терапьютикс, Лтд. Конденсированные бициклические соединения для лечения заболевания
TW201741307A (zh) * 2016-02-22 2017-12-01 艾洛斯生物製藥公司 Fxr調節劑及其使用方法
JP2020515564A (ja) 2017-03-30 2020-05-28 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル エピソーマルウイルスの持続性及び発現を低下させるための方法及び医薬組成物
AU2018313925A1 (en) * 2017-08-10 2020-02-27 The Texas A & M University System NR4A1 ligands, pharmaceutical compositions, and related methods of use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE523919A (cg-RX-API-DMAC7.html) * 1952-10-31
US2719162A (en) * 1954-03-29 1955-09-27 Eastman Kodak Co 5-(3-hydroxybenzylidene)-3-phenyl-2-phenylimino-4-thiazolidone and process
US3097100A (en) * 1960-01-25 1963-07-09 Eastman Kodak Co Thiazolidones as light stabilizers for plastic compositions
BE608790A (fr) * 1960-10-08 1962-04-03 Kalle Ag Matériel photosensible.
US3314794A (en) * 1964-05-13 1967-04-18 Eastman Kodak Co Ultraviolet absorbers
FR1604530A (cg-RX-API-DMAC7.html) * 1967-06-06 1971-11-29
US5198454A (en) * 1991-12-03 1993-03-30 Texas A&M University System Use of OB-104 to treat ocular inflammation
JPH06128234A (ja) * 1992-10-19 1994-05-10 Fuji Photo Film Co Ltd 不斉炭素原子を有する化合物およびそれからなる非線形光学材料
JP3871354B2 (ja) * 1994-07-29 2007-01-24 株式会社フジモト・コーポレーション 新規な2−(n−シアノイミノ)チアゾリジン−4−オン誘導体
US6353006B1 (en) * 1999-01-14 2002-03-05 Bayer Corporation Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
EP1465882B1 (en) * 2001-12-21 2011-08-24 X-Ceptor Therapeutics, Inc. Hetrocyclic modulators of nuclear receptors

Similar Documents

Publication Publication Date Title
US6107323A (en) Pharmaceutical composition
JP2023504415A5 (cg-RX-API-DMAC7.html)
JP2004520292A5 (cg-RX-API-DMAC7.html)
RU98119885A (ru) Фармацевтическая композиция, содержащая соединение, имеющее ангиотензин ii антагонистическую активность
HRP20141048T1 (hr) Spojevi, pripravci i metode
JP2007505091A5 (cg-RX-API-DMAC7.html)
JP2006513202A5 (cg-RX-API-DMAC7.html)
JP2009531280A5 (cg-RX-API-DMAC7.html)
JP2008528520A5 (cg-RX-API-DMAC7.html)
US20170112811A1 (en) Therapeutic agent for dyslipidemia
RU2008106058A (ru) Производные пиридазинона в качестве агонистов рецептора тиреоидного гормона
JP2022519131A5 (cg-RX-API-DMAC7.html)
JP2006514611A5 (cg-RX-API-DMAC7.html)
JP2005525371A5 (cg-RX-API-DMAC7.html)
JP2008513516A5 (cg-RX-API-DMAC7.html)
JP2008516968A5 (cg-RX-API-DMAC7.html)
JP2009528275A5 (cg-RX-API-DMAC7.html)
FI3827829T3 (fi) Ei-alkoholiperäisen rasvamaksan ehkäisyssä tai hoidossa käytettävä lääkekoostumus, joka sisältää vaikuttavana aineena gpr119-ligandin
JP2007527433A5 (cg-RX-API-DMAC7.html)
JP2007521312A5 (cg-RX-API-DMAC7.html)
AU2001258841B2 (en) Heterocyclic compounds
CN1333762A (zh) 新的2-(n-氰基亚氨基)噻唑烷-4-酮衍生物
EP0785781B1 (en) Use of indole derivatives for the treatment of dermatological disorders peripheral neuropathied, arthritis, allergic or chronic obstructive airways disease, glaucoma and ocular inflammation
JP2009524686A5 (cg-RX-API-DMAC7.html)
JP2022554330A5 (cg-RX-API-DMAC7.html)